
In today’s briefing:
- Global Markets: Why This Sell-Off Is Different and What It Signals
- Shell’s Next Phase: Leaner Operations, Stronger Cash Flow, and Higher Shareholder Returns
- [ETP 2025/14] WTI Plummets on Tariffs and OPEC Output Hike, Henry Hub Supported by Cooler Weather
- SP500: Friday Sell-Offs, the VIX, and a Bit of 1987
- Reynolds Consumer Products Reveals A New Strategy To Capture Retail Shelves Nationwide!
- Steven Madden Just Acquired Kurt Geiger—Is This The Start Of A Fashion Empire?
- Century Communities: The 5 Critical Challenges Lying Ahead in 2025!
- Bright Horizons’ Backup Care Boom: $600 Million Powerhouse Reshaping the Future of Childcare!
- BigCommerce’s Targeted B2B Expansion Plan & 5 Factors That Are Changing The Game!
- CTSO: CytoSorbents reports 4th quarter and 2024 financial results which showed impressive product revenue growth that was above our expectations.

Global Markets: Why This Sell-Off Is Different and What It Signals
- The SP500 and DXY both dropped yesterday—historically an unusual development.
- We examine the SP500-DXY relationship alongside long-term shifts in capital flow and what this could mean for global markets vs SP500.
- A distinct performance trend that began in 2009 may now be in the process of reversing.
Shell’s Next Phase: Leaner Operations, Stronger Cash Flow, and Higher Shareholder Returns
- Shell reaffirmed its strategy, prioritizing efficiency, LNG growth, and shareholder returns, unlike BP’s strategic shift back to hydrocarbons after an aggressive renewables push.
- As the world’s largest LNG trader, Shell plans 4%-5% annual LNG sales growth, capitalizing on rising global demand while maintaining financial discipline and emissions targets
- Shell aims to save USD 5 – 7 billion by 2028, cut capex to USD 20 – 22 billion, and streamline operations to enhance free cash flow and investor returns.
[ETP 2025/14] WTI Plummets on Tariffs and OPEC Output Hike, Henry Hub Supported by Cooler Weather
- For the week ending 28/Mar, U.S. crude inventories rose by 6.2m barrels (vs. expectations of 0.2k fall), and gasoline stockpiles fell less than expected.
- US natural gas inventories rose by 29 Bcf for the week ending 28/Mar, exceeding analyst expectations of a 27 Bcf build. Inventories are 4.3% below the 5-year seasonal average.
- Chevron sold its Texas gas assets for USD 525 million, while Exxon, Occidental, Schlumberger, and Aramco had their price targets cut.
SP500: Friday Sell-Offs, the VIX, and a Bit of 1987
- Drops greater than 5% on a Friday are rare, we examine historical returns after such events.
- We revisit 1987 price action and reconstructed VIX levels to add historical context.
- With circuit breakers now in place and political volatility elevated, we assess what today’s sell-off might mean for the next trading day.
Reynolds Consumer Products Reveals A New Strategy To Capture Retail Shelves Nationwide!
- Reynolds Consumer Products, Inc. reported its financial performance for the fourth quarter and full year of 2024.
- The company experienced a modest volumetric growth of 1% in the fourth quarter across its business units, which include Reynolds Cooking & Baking, Hefty Waste & Storage, Presto, and Hefty Tableware.
- Despite navigating a challenging market environment, the company achieved its strongest profitability since the COVID 19 surge in 2020, highlighted by expanded margins and earnings surpassing initial projections.
Steven Madden Just Acquired Kurt Geiger—Is This The Start Of A Fashion Empire?
- Steven Madden, Ltd. reported solid financial results for the full year 2024, with revenue increasing 15.2% year over-year to $2.3 billion and diluted earnings per share rising 9% to $2.67.
- The company emphasized four key business drivers: international expansion, category diversification beyond footwear, growth in direct-to-consumer (DTC) channels, and reinforcement of its U.S. wholesale footwear business.
- International revenue rose 12%, with notable growth in the EMEA region (18%), including Europe, the Middle East, and South Africa.
Century Communities: The 5 Critical Challenges Lying Ahead in 2025!
- Century Communities reported a record-breaking performance for both the fourth quarter and full year 2024, highlighted by increased deliveries and community expansion.
- The company delivered 11,007 homes in 2024, a 15% increase year-over-year, and expanded its community count by 28% to 322.
- This growth was robust despite fluctuating mortgage rates, which were offset by strategic incentives to drive sales.
Bright Horizons’ Backup Care Boom: $600 Million Powerhouse Reshaping the Future of Childcare!
- Bright Horizons Family Solutions concluded its fourth quarter and full-year 2024 with notable financial results, reflecting significant revenue and earnings growth.
- For the year, the company reported an 11% increase in total revenue and a remarkable 22% growth in adjusted EPS, surpassing initial projections.
- A key contributor to this performance was the back-up care segment, which exceeded expectations on revenue and operating income, thereby strengthening the company’s overall business mix.
BigCommerce’s Targeted B2B Expansion Plan & 5 Factors That Are Changing The Game!
- BigCommerce’s fourth quarter and fiscal year 2024 earnings announcement revealed a mixed financial performance as the company navigates its transformational strategy towards more efficient and profitable operations.
- The company’s non-GAAP operating income showed a remarkable improvement, surpassing $19 million, which is nearly double the original forecast, while operating cash flow reached $26 million, marking a $50 million increase from 2023.
- These outcomes underscore BigCommerce’s effective cost management, attributed to decreased ineffective sales and marketing expenditure and a 10% headcount reduction.
CTSO: CytoSorbents reports 4th quarter and 2024 financial results which showed impressive product revenue growth that was above our expectations.
- CytoSorbents is commercializing its E.U. approved CytoSorb blood purification technology to treat life-threatening conditions in the intensive care unit and cardiac surgery.
- The company also seeks U.S. and Canadian approval of a second product, DrugSorb-ATR, to reduce perioperative bleeding risk in patients on blood thinners during cardiac surgery.
- Based on the results of its pivotal U.S. and Canadian STAR-T trial, the company submitted for FDA De Novo approval on September 27, 2024, and Health Canada on November 1, 2024, with regulatory decisions expected in 2025.